Skip to Content

WPI 3631 (Hydromorphone Hydrochloride Extended-Release 32 mg)

Pill with imprint WPI 3631 is White, Round and has been identified as Hydromorphone Hydrochloride Extended-Release 32 mg. It is supplied by Actavis Pharma, Inc..

Hydromorphone is used in the treatment of chronic pain; pain; cough; anesthetic adjunct and belongs to the drug class narcotic analgesics. Risk cannot be ruled out during pregnancy. Hydromorphone 32 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).

Images for WPI 3631

Hydromorphone hydrochloride extended-release 32 mg WPI 3631

Hydromorphone Hydrochloride Extended-Release

Imprint
WPI 3631
Strength
32 mg
Color
White
Size
10.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Narcotic analgesics
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
2 - High potential for abuse
Labeler / Supplier
Actavis Pharma, Inc.
National Drug Code (NDC)
00591-3631
Inactive Ingredients
cellulose acetate, copovidone, hypromelloses, ferrosoferric oxide, lactose monohydrate, magnesium stearate, polyethylene glycol, propylene glycol, sodium chloride, magnesium silicate, titanium dioxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.